Peripheral Neuropathies
Diabetic amyotrophy
Jan. 29, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
A bolus of fluorescein dye is injected into a vein in the arm. It begins to appear in the eye 10 to 20 seconds later if the injection is not prolonged and the patient’s circulation is normal. The dye, which is made to fluoresce, is first seen in the choroidal circulation followed by the retinal arteriole. This figure represents an early arteriole phase. (Contributed by Dr. James Walters.)